cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.18743/data.00160
title: Dungeness beach GPR and topographic survey

description: Ground-penetrating radar (GPR) survey of shingle beach ridges at Dungeness, UK. Data collected using Pulse EKKO Pro GPR with 200 MHz antennas. There are 7 GPR profiles perpendicular to the coastline, Beach 1-7. They start next to the coast road and head towards the sea in 50m sections labelled A, B, C etc. The GPR data is in the .dt files while header data describing each file is .hd. Topographic data collected for static elevation corrections at 1 m intervals along the line of section is in 7 .top files.
description: Pulse Ekko Pro GPR data with 200 MhZ antennas, parallel broadside configuration, 0.5 m separation, 0.1 m steps, 64 stacks, 350 ns time window. Leica level topographic data every meter along the GPR profiles.
DOI: 10.3886/e148402
title: Distance Teaching During the COVID-19 Crisis: Social Connectedness Matters Most for Teaching Quality and Students’ Learning

description: In spring 2020, school closures were enacted to slow the spread of the COVID-19 pandemic. Students and teachers faced the challenge of organizing digital teaching and learning without sufficient time to prepare. In this study, we investigated how teachers implemented teaching from a distance and how these different implementations were associated with students’ and parents’ perceptions of teaching quality and students’ social involvement, enjoyment of learning, academic effort, and perceived competence. To this end, we examined data from 277 teachers, 3,159 students in Grades 5 to 10, and 1,688 parents who rated classes in mathematics, German language arts, and English as a foreign language during the school closures. The results showed that teachers’ implementations of distance teaching varied greatly. Teaching methods enabling social connectedness (e.g., video meetings, learning videos created by the teacher) revealed the most consistent positive associations with students’ and parents’ teaching quality ratings and students’ learning experiences.
DOI: 10.5281/zenodo.3773250
title: DUPS: Diachronic Usage Pair Similarity

description: The DUPS (Diachronic Usage Pair Similarity) dataset contains similarity judgements of English word usage pairs from different time periods, as described in the following paper. Please cite this paper if you use the dataset in your work. Mario Giulianelli, Marco Del Tredici, and Raquel Fernández. 2020. Analysing Lexical Semantic Change with Contextualised Word Representations. In <em>Proceedings of the 58th Annual Meeting of the Association for Computational Linguistics (ACL-2020)</em>. Association for Computational Linguistics.
DOI: 10.48370/ofd/scaelw/1kokrh
title: HMW_Ledum_palustre_L._H_1043.jpg

description: :unav
DOI: 10.48370/ofd/scaelw
title: Bagno zwyczajne (Ledum palustre L.), 1043

description: Herbarium
DOI: 10.48370/ofd/lp7pc6/sulktr
title: HMW_Ledum_palustre_L._H_1717.jpg

description: :unav
DOI: 10.48370/ofd/lp7pc6
title: Bagno zwyczajne (Ledum palustre L.), 1717

description: Herbarium
DOI: 10.48370/ofd/qhtwhq/6jnwym
title: HMW_Ledum_palustre_L._H_2399.jpg

description: :unav
DOI: 10.48370/ofd/qhtwhq
title: Bagno zwyczajne (Ledum palustre L.), 2399

description: Herbarium
DOI: 10.48370/ofd/oehpap/e8fo6j
title: HMW_Ledum_palustre_L._H_0529.jpg

description: :unav
DOI: 10.48370/ofd/oehpap
title: Bagno zwyczajne (Ledum palustre L.), 529

description: Herbarium
DOI: 10.48370/ofd/lhjuyo/6r2tlr
title: HMW_Ledum_palustre_L._H_0566.jpg

description: :unav
DOI: 10.48370/ofd/lhjuyo
title: Bagno zwyczajne (Ledum palustre L.), 566

description: Herbarium
DOI: 10.48370/ofd/eicicb/k49rfy
title: HMW_Ledum_palustre_L._H_5969.jpg

description: :unav
DOI: 10.48370/ofd/eicicb
title: Bagno zwyczajne (Ledum palustre L.), 5969

description: Herbarium
DOI: 10.48370/ofd/oqaigl/jd6hfh
title: HMW_Ledum_palustre_L._H_8154.jpg

description: :unav
DOI: 10.48370/ofd/oqaigl
title: Bagno zwyczajne (Ledum palustre L.), 8154

description: Herbarium
DOI: 10.48370/ofd/hjx9vt/mykhps
title: HMW_Ocimum_basilium_L._H_05524.jpg

description: :unav
DOI: 10.48370/ofd/hjx9vt
title: Bazylia pospolita (Ocimum basilium L.), 5524

description: Herbarium
DOI: 10.48370/ofd/o4gxvw/mholfb
title: HMW_Peplis_portula_L._H_1611.jpg

description: :unav
DOI: 10.48370/ofd/o4gxvw
title: Bebłek błotny (Peplis portula L.), 1611

description: Herbarium
DOI: 10.48370/ofd/n8sxw7/tqbeay
title: HMW_Peplis_portula_L._H_4548.jpg

description: :unav
DOI: 10.48370/ofd/n8sxw7
title: Bebłek błotny (Peplis portula L.), 4548

description: Herbarium
DOI: 10.48370/ofd/ti21ro/bb3uo4
title: HMW_Peplis_portula_L._H_6590.jpg

description: :unav
DOI: 10.48370/ofd/ti21ro
title: Bebłek błotny (Peplis portula L.), 6590

description: Herbarium
DOI: 10.48370/ofd/tt2f45/ja2wlf
title: HMW_Peplis_portula_L._H_6591.jpg

description: :unav
DOI: 10.48370/ofd/tt2f45
title: Bebłek błotny (Peplis portula L.), 6591

description: Herbarium
DOI: 10.15161/oar.it/74082
title: CovidStat project data

description: This record contains the daily updated data of the CovidStat project. CovidStat is a project carried out by the CovidStat Working Group at INFN, whose creation was promoted within the Italian National Institute of Nuclear Physics with the aim of making a statistical analysis of the data provided daily by the Civil Protection on the spread of the pandemic in Italy. CovidStat data can interactively be browsed at https://covid19.infn.it.
description: The software to process this Root TTree is in the related identifier. Be sure to use the right corresponding version, based on the data in which Root TTree was generated.
DOI: 10.48370/ofd/52pipu/l98nej
title: HMW_Peplis_portula_L._H_8312.jpg

description: :unav
DOI: 10.48370/ofd/52pipu
title: Bebłek błotny (Peplis portula L.), 8312

description: Herbarium
DOI: 10.48370/ofd/zsmnew/sjr1nq
title: HMW_Peplis_portula_L._H_8340.jpg

description: :unav
DOI: 10.48370/ofd/zsmnew
title: Bebłek błotny (Peplis portula L.), 8340

description: Herbarium
DOI: 10.48370/ofd/375ya3/xsjy8g
title: HMW_Peplis_portula_L._H_8390.jpg

description: :unav
DOI: 10.48370/ofd/375ya3
title: Bebłek błotny (Peplis portula L.), 8390

description: Herbarium
DOI: 10.48370/ofd/za3jal/hn5hd2
title: HMW_Nardus_stricta_L._H_4959.jpg

description: :unav
DOI: 10.48370/ofd/za3jal
title: Bliźniczka psia trawka (Nardus stricta L.), 4959

description: Herbarium
DOI: 10.48370/ofd/qv4iso/e9adse
title: HMW_Nardus_stricta_L._H_9417.jpg

description: :unav
DOI: 10.48370/ofd/qv4iso
title: Bliźniczka psia trawka (Nardus stricta L.), 9417

description: Herbarium
DOI: 10.5281/zenodo.5494458
title: dataset related to article "ACCEPTANCE AND COMMITMENT THERAPY FOR HIGH FREQUENCY EPISODIC MIGRAINE WITHOUT AURA FINDINGS FROM A RANDOMIZED PILOT INVESTIGATION"

description: Dataset including data (SSPS files .sav) referred to the Italian subsample of the “ACT for Migraine” multicenter study
DOI: 10.5281/zenodo.5494457
title: dataset related to article "ACCEPTANCE AND COMMITMENT THERAPY FOR HIGH FREQUENCY EPISODIC MIGRAINE WITHOUT AURA FINDINGS FROM A RANDOMIZED PILOT INVESTIGATION"

description: Dataset including data (SSPS files .sav) referred to the Italian subsample of the “ACT for Migraine” multicenter study
DOI: 10.25550/2-hr74
title: Bootcamp self-guided tutorial dataset

description: This dataset can be used as a guide for the self-guided tutorial demonstrated during the FaceBase Bootcamp on 09/08/2021. The practice data can be downloaded from the Supplementary Files section below.
DOI: 10.48370/ofd/gwjasp/jg97q0
title: HMW_Myriophyllum_verticillatum_L._H_5133.jpg

description: :unav
DOI: 10.48370/ofd/gwjasp
title: Wywłócznik okółkowy (Myriophyllum verticillatum L.), 5133

description: Herbarium
DOI: 10.5281/zenodo.5494460
title: Dataset related to article "WITHDRAWAL FAILURE IN PATIENTS WITH CHRONIC MIGRAINE AND MEDICATION OVERUSE HEADACHE"

description: The file contains baseline and follow-up data (SPSS FILES .sav) referred to the MOH-COST study, used for a secondary analysis
DOI: 10.5281/zenodo.5494459
title: Dataset related to article "WITHDRAWAL FAILURE IN PATIENTS WITH CHRONIC MIGRAINE AND MEDICATION OVERUSE HEADACHE"

description: The file contains baseline and follow-up data (SPSS FILES .sav) referred to the MOH-COST study, used for a secondary analysis
DOI: 10.5281/zenodo.5494423
title: Analysis of websites, social media pages and apps for the development of new strategies for increasing participation of women in clinical trials

description: For T2.5 of the i-CONSENT project, an analysis was undertaken of the strategies used to effectively communicate with women on the topic of women’s health or women’s health research, considering aspects such as tone, format and audience interaction. A total of 42 websites, social media pages and apps were included in the analysis. The attached document presents the findings from the data generation stage of this analysis.
DOI: 10.5281/zenodo.5116112
title: Analysis of websites, social media pages and apps for the development of new strategies for increasing participation of women in clinical trials

description: For T2.5 of the i-CONSENT project, an analysis was undertaken of the strategies used to effectively communicate with women on the topic of women’s health or women’s health research, considering aspects such as tone, format and audience interaction. A total of 42 websites, social media pages and apps were included in the analysis. The attached document presents the findings from the data generation stage of this analysis.
DOI: 10.5281/zenodo.5464149
title: Dataset related to article "Manipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetes"

description: <em>The files contain raw data related to the article "Manipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetes", available from https://www.nature.com/articles/s41598-020-65423-0.</em> <strong>Abstract of the manuscript</strong>: More effective treatments for diabetic nephropathy remain a major unmet clinical need. Increased oxidative stress is one of the most important pathological mechanisms that lead to kidney damage and functional impairment induced by diabetes. Sirtuin 3 (SIRT3) is the main mitochondrial deacetylase and critically regulates cellular reactive oxygen species (ROS) production and detoxification. Honokiol is a natural biphenolic compound that, by activating mitochondrial SIRT3, can carry out anti-oxidant, anti-inflammatory and anti-fibrotic activities. Here, we sought to investigate the renoprotective effects of honokiol in BTBR <em>ob/ob</em> mice with type 2 diabetes. Diabetic mice were treated with vehicle or honokiol between the ages of 8 and 14 weeks. Wild-type mice served as controls. Renal <em>Sirt3</em> expression was significantly reduced in BTBR <em>ob/ob</em> mice, and this was associated with a reduction in its activity and increased ROS levels. Selective activation of SIRT3 through honokiol administration translated into the attenuation of albuminuria, amelioration of glomerular damage, and a reduction in podocyte injury. SIRT3 activation preserved mitochondrial wellness through the activation of SOD2 and the restoration of PGC-1α expression in glomerular cells. Additionally, the protective role of SIRT3 in glomerular changes was associated with enhanced tubular <em>Sirt3</em> expression and upregulated renal <em>Nampt</em> levels, indicating a possible tubule-glomerulus retrograde interplay, which resulted in improved glomerular SIRT3 activity. Our results demonstrate the hitherto unknown renoprotective effect of SIRT3 against diabetic glomerular disease and suggest that the pharmacological modulation of SIRT3 activity is a possible novel approach to treating diabetic nephropathy.
description: This study was supported by Fondazione Cariplo (grant Giovani Ricercatori 2016 Rif. 2016-0500).
description: {"references": ["Locatelli M, Zoja C, Zanchi C, Corna D, Villa S, Bolognini S, Novelli R, Perico L, Remuzzi G, Benigni A, Cassis P. Manipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetes. Sci Rep. 2020 May 21;10(1):8418. doi: 10.1038/s41598-020-65423-0. PMID: 32439965; PMCID: PMC7242337."]}
DOI: 10.6084/m9.figshare.15090624
title: Supplementary Material for: Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure

description: Medicine
DOI: 10.6084/m9.figshare.15090624.v1
title: Supplementary Material for: Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure

description: Medicine
DOI: 10.5281/zenodo.5464148
title: Dataset related to article "Manipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetes"

description: <em>The files contain raw data related to the article "Manipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetes", available from https://www.nature.com/articles/s41598-020-65423-0.</em> <strong>Abstract of the manuscript</strong>: More effective treatments for diabetic nephropathy remain a major unmet clinical need. Increased oxidative stress is one of the most important pathological mechanisms that lead to kidney damage and functional impairment induced by diabetes. Sirtuin 3 (SIRT3) is the main mitochondrial deacetylase and critically regulates cellular reactive oxygen species (ROS) production and detoxification. Honokiol is a natural biphenolic compound that, by activating mitochondrial SIRT3, can carry out anti-oxidant, anti-inflammatory and anti-fibrotic activities. Here, we sought to investigate the renoprotective effects of honokiol in BTBR <em>ob/ob</em> mice with type 2 diabetes. Diabetic mice were treated with vehicle or honokiol between the ages of 8 and 14 weeks. Wild-type mice served as controls. Renal <em>Sirt3</em> expression was significantly reduced in BTBR <em>ob/ob</em> mice, and this was associated with a reduction in its activity and increased ROS levels. Selective activation of SIRT3 through honokiol administration translated into the attenuation of albuminuria, amelioration of glomerular damage, and a reduction in podocyte injury. SIRT3 activation preserved mitochondrial wellness through the activation of SOD2 and the restoration of PGC-1α expression in glomerular cells. Additionally, the protective role of SIRT3 in glomerular changes was associated with enhanced tubular <em>Sirt3</em> expression and upregulated renal <em>Nampt</em> levels, indicating a possible tubule-glomerulus retrograde interplay, which resulted in improved glomerular SIRT3 activity. Our results demonstrate the hitherto unknown renoprotective effect of SIRT3 against diabetic glomerular disease and suggest that the pharmacological modulation of SIRT3 activity is a possible novel approach to treating diabetic nephropathy.
description: This study was supported by Fondazione Cariplo (grant Giovani Ricercatori 2016 Rif. 2016-0500).
description: {"references": ["Locatelli M, Zoja C, Zanchi C, Corna D, Villa S, Bolognini S, Novelli R, Perico L, Remuzzi G, Benigni A, Cassis P. Manipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetes. Sci Rep. 2020 May 21;10(1):8418. doi: 10.1038/s41598-020-65423-0. PMID: 32439965; PMCID: PMC7242337."]}
DOI: 10.6084/m9.figshare.16586327
title: Supplementary Material for: Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival

description: <b><i>Background & Aims:</i></b> Intermediate hepatocellular carcinoma (HCC) treatment has become complicated due to the development of various molecular-targeted agents (MTAs). We aimed to determine whether the administration of MTAs in patients with intermediate-stage HCC contributed to the prevention of progression to an advanced stage. <b><i>Methods:</i></b> We enrolled and retrospectively examined 289 patients with Child-Pugh class A who had been diagnosed with intermediate-stage HCC and underwent initial trans-arterial chemoembolization (TACE). Patients were classified into 2 groups: a group in which MTAs were administered to patients whose condition was refractory to TACE (<i>n</i> = 65) and a group in which MTAs were not administered (<i>n</i> = 65) at intermediate-stage HCC after propensity score matching (PSM). Time to stage progression (TTSP) and overall survival (OS) were calculated using the Kaplan-Meier method and analyzed using a log-rank test after PSM. <b><i>Results:</i></b> TTSP and OS of the group with MTA administration were significantly longer than those of the group without MTA administration (TTSP: 36.4 vs. 17.9 months, <i>p</i> &lt; 0.001; median survival time [MST]: 44.6 vs. 26.6 months, <i>p</i> = 0.001). Within the up-to-seven criteria and administration of MTAs at the intermediate-stage HCC were identified as independent factors for TTSP and OS in the multivariate analysis. TTSP and OS in the era of the multi-MTA group were significantly longer than those in the era of the mono-MTA group (TTSP: 44.8 vs. 27.4 months, <i>p</i> = 0.01; MST: 53.4 vs. 33.3 months, <i>p</i> = 0.01). <b><i>Conclusion:</i></b> The administration of MTAs in patients with intermediate-stage HCC contributes to the prevention of stage progression and prolongs OS.
DOI: 10.6084/m9.figshare.16586327.v1
title: Supplementary Material for: Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival

description: <b><i>Background & Aims:</i></b> Intermediate hepatocellular carcinoma (HCC) treatment has become complicated due to the development of various molecular-targeted agents (MTAs). We aimed to determine whether the administration of MTAs in patients with intermediate-stage HCC contributed to the prevention of progression to an advanced stage. <b><i>Methods:</i></b> We enrolled and retrospectively examined 289 patients with Child-Pugh class A who had been diagnosed with intermediate-stage HCC and underwent initial trans-arterial chemoembolization (TACE). Patients were classified into 2 groups: a group in which MTAs were administered to patients whose condition was refractory to TACE (<i>n</i> = 65) and a group in which MTAs were not administered (<i>n</i> = 65) at intermediate-stage HCC after propensity score matching (PSM). Time to stage progression (TTSP) and overall survival (OS) were calculated using the Kaplan-Meier method and analyzed using a log-rank test after PSM. <b><i>Results:</i></b> TTSP and OS of the group with MTA administration were significantly longer than those of the group without MTA administration (TTSP: 36.4 vs. 17.9 months, <i>p</i> &lt; 0.001; median survival time [MST]: 44.6 vs. 26.6 months, <i>p</i> = 0.001). Within the up-to-seven criteria and administration of MTAs at the intermediate-stage HCC were identified as independent factors for TTSP and OS in the multivariate analysis. TTSP and OS in the era of the multi-MTA group were significantly longer than those in the era of the mono-MTA group (TTSP: 44.8 vs. 27.4 months, <i>p</i> = 0.01; MST: 53.4 vs. 33.3 months, <i>p</i> = 0.01). <b><i>Conclusion:</i></b> The administration of MTAs in patients with intermediate-stage HCC contributes to the prevention of stage progression and prolongs OS.
DOI: 10.14278/rodare.1135
title: APR files

description: APR files for 4 different functions
DOI: 10.14278/rodare.1134
title: APR files

description: APR files for 4 different functions
DOI: 10.6084/m9.figshare.16586294
title: Supplementary Material for: Denosumab-Induced Hypocalcemia and Hyperparathyroidism in de novo Kidney Transplant Recipients

description: <b><i>Introduction:</i></b> Denosumab represents a realistic treatment option to increase bone mineral density in kidney transplant recipients (KTRs). It is still unknown how and at what extent posttransplantation bone disease and graft function influence the effects of denosumab on mineral metabolism indexes. In this study, we analyze risk factors of hypocalcemia and parathyroid hormone (PTH) increase after denosumab administration in eighteen de novo KTRs and its management before and after this treatment. <b><i>Methods:</i></b> We conducted a monocentric, observational, prospective study on de novo KTRs. All KTRs enrolled received a single 60 mg subcutaneous dose of denosumab every 6 months. Before kidney transplantation, no patients were treated with calcio-mimetic. After kidney transplantation and before antiresorptive therapy, no patients were treated with calcio-mimetic drugs and/or vitamin D receptor agonists, while all patients received nutritional vitamin D supplementation (from 1,000 IU to 1,500 IU daily). <b><i>Results:</i></b> Hypocalcemia was related to the degree of lumbar osteoporosis (<i>p</i> = 0.047); the increase in the PTH level was correlated to baseline bone turnover markers (bone alkaline phosphatase, serum osteocalcin, and β-C-terminal telopeptide), the 25 OH status, and eGFR. The introduction of calcitriol, after the PTH increase, in addition to cholecalciferol was necessary to ensure an adequate control of serum calcium and PTH during a follow-up of 15 months. Following the treatment with denosumab, it was observed an improvement of areal bone mineral density both at lumbar and femoral sites with a mean percentual increase of 1.74% and 0.25%, respectively. <b><i>Conclusions:</i></b> Denosumab is an effective treatment for bone disease in KTRs. In our study, the increase in PTH is not a transient event but prolonged throughout the follow-up period and requires continuous supplementation therapy with calcitriol.
DOI: 10.6084/m9.figshare.16586294.v1
title: Supplementary Material for: Denosumab-Induced Hypocalcemia and Hyperparathyroidism in de novo Kidney Transplant Recipients

description: <b><i>Introduction:</i></b> Denosumab represents a realistic treatment option to increase bone mineral density in kidney transplant recipients (KTRs). It is still unknown how and at what extent posttransplantation bone disease and graft function influence the effects of denosumab on mineral metabolism indexes. In this study, we analyze risk factors of hypocalcemia and parathyroid hormone (PTH) increase after denosumab administration in eighteen de novo KTRs and its management before and after this treatment. <b><i>Methods:</i></b> We conducted a monocentric, observational, prospective study on de novo KTRs. All KTRs enrolled received a single 60 mg subcutaneous dose of denosumab every 6 months. Before kidney transplantation, no patients were treated with calcio-mimetic. After kidney transplantation and before antiresorptive therapy, no patients were treated with calcio-mimetic drugs and/or vitamin D receptor agonists, while all patients received nutritional vitamin D supplementation (from 1,000 IU to 1,500 IU daily). <b><i>Results:</i></b> Hypocalcemia was related to the degree of lumbar osteoporosis (<i>p</i> = 0.047); the increase in the PTH level was correlated to baseline bone turnover markers (bone alkaline phosphatase, serum osteocalcin, and β-C-terminal telopeptide), the 25 OH status, and eGFR. The introduction of calcitriol, after the PTH increase, in addition to cholecalciferol was necessary to ensure an adequate control of serum calcium and PTH during a follow-up of 15 months. Following the treatment with denosumab, it was observed an improvement of areal bone mineral density both at lumbar and femoral sites with a mean percentual increase of 1.74% and 0.25%, respectively. <b><i>Conclusions:</i></b> Denosumab is an effective treatment for bone disease in KTRs. In our study, the increase in PTH is not a transient event but prolonged throughout the follow-up period and requires continuous supplementation therapy with calcitriol.